Jun25 Quarterly Activities Statement and Appendix 4C
Released
Released
Announcement PDF
ASX ANNOUNCEMENT
30 July 2025
HITIQ Quarterly Activities Report
June 2025
Highlights
>
PROTEQT Commercial Launch: HITIQ successfully launched its flagship PROTEQT smart
mouthguard system in the consumer market, marking a pivotal shift from elite sports to
grassroots community athletics.
>
Exclusive Global Shock Doctor Partnership: Secured a landmark 5-year exclusive global
agreement with Shock Doctor, the world's #1 mouthguard brand, creating the world's first selffit instrumented concussion mouthguard with production scaling to 100,000 units by 2026.
>
Strategic Grassroots Partnerships Expanded: New multi-year partnerships secured with AFL
Barwon (25,000+ players) and South Metro Junior Football League (10,000+ players),
complementing existing agreements with VAFA and Westfield Sports High.
>
Capital Raising Completed: Successfully raised $1.9 million through a placement ($680k) and
partially underwritten rights issue $1.2 million to fund consumer market expansion and global
manufacturing capacity.
>
Enhanced R&D Funding: Additional $420,000 drawdown from R&D loan facility, bringing total
utilisation to $1.42 million with RDTI refund expected by December 2025.
>
Additional Loan from Harmil Angel Investments of $500,000 payable in 6 months.
Operational and Strategic Updates
HITIQ Limited (ASX: HIQ) achieved transformative commercial milestones during the June 2025 quarter,
successfully launching its consumer-focused PROTEQT system and establishing infrastructure for global scale.
PROTEQT: World-First Technology Partnership
Following a two-year co-development phase, HITIQ signed an exclusive global manufacturing and distribution
agreement with Shock Doctor. This groundbreaking partnership delivers the first self-fit instrumented
mouthguard, integrating HITIQ's proprietary sensor technology into Shock Doctor's proven chassis design.
HITIQ LTD
ASX: HIQ
ACN 609 543 213
Unit 4/38–42 White Street South Melbourne, VIC 3205
investors@hitiq.com
www.hitiq.com
The co-branded HITIQ/SHOCK PROTEQT mouthguard combines impact detection, symptom assessment, and
7-day telehealth support using the Sports Concussion Assessment Tool (SCAT).
Production is underway through Stang Precision for 2025 requirements, with manufacturing capacity scaling
to 100,000 units in 2026. HITIQ will distribute directly in Australia (AUD $349 including GST) and the UK (GBP
£199 including VAT).
Grassroots Market Expansion
HITIQ secured new multi-year partnerships with AFL Barwon (25,000+ players) and South Metro Junior
Football League (10,000+ players), establishing HITIQ as Official Concussion Technology Partner for both
organisations. Combined with existing VAFA (15,000+ players) and Westfield Sports High partnerships, HITIQ
now has direct access to over 50,000 athletes across Australia's community sports sector.
The addressable market represents significant revenue potential: Australia's collision sports participants total
approximately 971,050 athletes (TAM of ~$310 million), with international markets in the UK and US adding a
further $3.75 billion opportunity.
Market Outlook
HITIQ's successful PROTEQT launch positions the Company to capture market share in the growing concussion
management sector. The combination of proven elite sports technology, strategic community partnerships,
and global manufacturing capability creates a scalable platform for sustainable growth.
With industry estimates suggesting significant portions of Australia's 100,000 annual sports-related
concussions go undetected at grassroots level, PROTEQT addresses a critical market need through accessible,
easy-to-use technology.
Upcoming Initiatives
•
•
•
•
Shareholder Town Hall webinar on PROTEQT system details.
Expansion of community sports partnerships across rugby league and union.
International market development in the UK and US.
Product enhancement for additional recurring revenue streams.
Financial
The company had cash reserves of A$934,689 as at 30th June 2025.
Capital Raising
HITIQ raised $1.9 million comprising:
•
•
•
Placement: $680,000 through 30,909,091 shares at $0.022 per share
Rights Issue: Up to $2.9million to eligible shareholders, partially underwritten to $1.2 million.
Option Attachments: One free attaching option (exercisable at $0.022, expiring December 30, 2028)
for every two shares issued.
The company is looking to close out the shortfall from the rights issue in the coming weeks.
HITIQ.COM
Use of Funds
•
•
•
•
•
•
Manufacturing capacity expansion (22.5%)
USA market expansion (25%)
Product enhancement (15%)
Business development and marketing (15%)
Continued R&D and AI capability (12.5%)
Working capital and costs (10%)
R&D Funding and Loan
An additional $420,000 drawdown from R&D loan facility with Rockford RDF Pty Ltd brings total utilisation to
$1.22 million, with repayment expected on or before December 31, 2025.
A short-term Loan of $500,000 from Harmil Angel Investments repayable on or before December 31, 2025.
Related Party Payments
As advised in Section 6.1 in the Appendix $c for the period, payments to, or an associate of, a related party of
the entity during the quarter totaled $120,829 comprising executive and non-executive director
remuneration, company secretarial services, and professional advisory fees.
•
•
•
•
Executive Director Salary and Superannuation
Non–Executive Director Fees
Company Secretarial Fees provided by Fernville Group,
o A related party of Non-Executive Director, Mr. James Barrie
Bookkeeping, Accounting and Taxation Services provided by Optima Partners,
o A related party of Non-Executive Director, Mr. Philip Carulli
$72,046
$37,668
$8,621
$21,783
As per the resolution passed at the 2024 AGM directors also received payments in lieu of outstanding
Directors Fees.
Conclusion
The June 2025 quarter represents a watershed moment for HITIQ, successfully transitioning from
development to commercial operations while establishing the foundation for global scale. The Company's
strategic partnerships, innovative technology, and strong financial position provide a robust platform for
capturing significant growth opportunities in the consumer concussion management market.
- ENDS –
Authorised for release by the Board of Directors.
For more information, contact: investors@hitiq.co
HITIQ.COM
HITIQ.COM
APPENDIX 4C
Quarterly cash flow report for entities
subject to listing rule 4.7b
Name of entity
HITIQ Limited
ABN
Quarter ended (“current quarter”)
53 609 543 213
Consolidated statement of cash flows
1.
Cash flows from operating activities
1.1
Receipts from customers
1.2
Payments for
(a) research and development
30th June 2025
Current quarter
$A’000
Year to date (12
months)
$A’000
178
731
(512)
(1,087)
(73)
(295)
(1,041)
(3,886)
(171)
(2,194)
-
(b) product manufacturing and
operating costs
(c) advertising and marketing
(d) leased assets
(e) staff costs
(f)
administration and corporate costs
1.3
Dividends received (see note 3)
-
1.4
Interest received
-
1.5
Interest and other costs of finance paid
-
-
1.6
Income taxes paid
-
-
1.7
Government grants and tax incentives
-
1,600
1.8
Other (Foreign Exchange Loss)
-
118
1.9
Net cash from / (used in) operating
activities
(1,619)
(5,009)
2.
Cash flows from investing activities
2.1
Payments to acquire or for:
(a) entities
-
-
(b) businesses
-
-
(c) property, plant and equipment
(4)
4
(27)
(d) investments
-
-
(e) intellectual property
-
-
-
-
(f)
other non-current assets
HITIQ.COM
Consolidated statement of cash flows
2.2
Current quarter
$A’000
Year to date (12
months)
$A’000
Proceeds from disposal of:
(g) entities
-
-
(h) businesses
-
-
(i)
property, plant and equipment
-
-
(j)
investments
-
-
-
-
-
-
(k) intellectual property
(l)
other non-current assets
2.3
Cash flows from loans to other entities
-
-
2.4
Dividends received (see note 3)
-
-
2.5
Other (provide details if material)
-
-
2.6
Net cash from / (used in) investing
activities
(4)
(27)
3.
Cash flows from financing activities
3.1
Proceeds from issues of equity securities
(excluding convertible debt securities)
1,489
1,943
3.2
Proceeds from issue of convertible debt
securities
-
-
3.3
Proceeds from exercise of options
-
-
3.4
Transaction costs related to issues of
equity securities or convertible debt
securities
(81)
(81)
3.5
Proceeds from borrowings
920
5,220
3.6
Repayment of borrowings
-
(1,687)
3.7
Transaction costs related to loans and
borrowings
-
-
3.8
Dividends paid
-
-
3.9
Other (provide details if material)
-
-
3.10
Net cash from / (used in) financing
activities
2,328
5,395
4.
Net increase / (decrease) in cash and
cash equivalents for the period
4.1
Cash and cash equivalents at beginning
of period
230
576
4.2
Net cash from / (used in) operating
activities (item 1.9 above)
(1,619)
(5,009)
4.3
Net cash from / (used in) investing
activities (item 2.6 above)
(4)
(27)
4.4
Net cash from / (used in) financing
activities (item 3.10 above)
2,328
5,395
HITIQ.COM
Consolidated statement of cash flows
Current quarter
$A’000
Year to date (12
months)
$A’000
4.5
Effect of movement in exchange rates
on cash held
-
-
4.6
Cash and cash equivalents at end of
period
935
935
5.
Reconciliation of cash and cash
equivalents
at the end of the quarter (as shown in
the consolidated statement of cash
flows) to the related items in the
accounts
Current quarter
$A’000
Previous quarter
$A’000
5.1
Bank balances
935
230
5.2
Call deposits
-
-
5.3
Bank overdrafts
-
-
5.4
Other (provide details)
-
-
5.5
Cash and cash equivalents at end of
quarter (should equal item 4.6 above)
935
230
6.
Payments to related parties of the entity and their
associates
6.1
Aggregate amount of payments to related parties and their
associates included in item 1
140
6.2
Aggregate amount of payments to related parties and their
associates included in item 2
-
Current quarter
$A'000
Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must
include a description of, and an explanation for, such payments.
7.
Financing facilities
Note: the term “facility’ includes all
forms of financing arrangements
available to the entity.
Total facility
amount at quarter
end
$A’000
Amount drawn at
quarter end
$A’000
5,400
5,400
Add notes as necessary for an
understanding of the sources of finance
available to the entity.
7.1
Loan facilities
7.2
Credit standby arrangements
-
-
7.3
Other (please specify)
-
-
7.4
Total financing facilities
5,400
5,400
7.5
Unused financing facilities available at quarter end
7.6
Include in the box below a description of each facility above, including the lender,
interest rate, maturity date and whether it is secured or unsecured. If any additional
financing facilities have been entered into or are proposed to be entered into after
quarter end, include a note providing details of those facilities as well.
-
HITIQ.COM
R&D Finance facility of $1,220,000 with Rockford Pty Ltd. Secured against R&D
Refund. Term 150 days, the R&D refund, interest rate 15% per annum. Additionally, the
company has entered into a convertible note facility with its major shareholder,
Harmil Angel Investments for $4,600,000 for a period of 12 months at an interest rate
of 12.5%, and the final $500,000 was drawn on the 22 January 2025.
8.
Estimated cash available for future operating activities
$A’000
8.1
Net cash from / (used in) operating activities (item 1.9)
(1,653)
8.2
Cash and cash equivalents at quarter end (item 4.6)
935
8.3
Unused finance facilities available at quarter end (item 7.5)
8.4
Total available funding (item 8.2 + item 8.3)
935
8.5
Estimated quarters of funding available (item 8.4 divided by
item 8.1)
0.57
-
Note: if the entity has reported positive net operating cash flows in item 1.9, answer
item 8.5 as “N/A”. Otherwise, a figure for the estimated quarters of funding available
must be included in item 8.5.
8.6
If item 8.5 is less than 2 quarters, please provide answers to the following questions:
8.6.1
Does the entity expect that it will continue to have the current level of net
operating cash flows for the time being and, if not, why not?
Answer: Yes, cashflows to continue
8.6.2
Has the entity taken any steps, or does it propose to take any steps, to raise
further cash to fund its operations and, if so, what are those steps and how
likely does it believe that they will be successful?
Answer: The company is continuing to raise capital under its shortfall offer in
accordance with the rights issue Prospectus dated 12 June 2025.
8.6.3
Does the entity expect to be able to continue its operations and to meet its
business objectives and, if so, on what basis?
Answer: Yes, the company expects to be able to continue its operations and meet its
business objectives on the basis of the expected implementation and
completion of the activities outlined in 8.6.2.
Note: where item 8.5 is less than 2 quarters, all of questions 8.6.1, 8.6.2 and 8.6.3
above must be answered.
Compliance statement
1
This statement has been prepared in accordance with accounting standards and policies
which comply with Listing Rule 19.11A.
2
This statement gives a true and fair view of the matters disclosed.
Date: 30 July 2025
Authorised by: The Board of HITIQ Limited
(Name of body or officer authorising release – see note 4)
HITIQ.COM
Notes
1.
This quarterly cash flow report and the accompanying activity report provide a basis for informing the market
about the entity’s activities for the past quarter, how they have been financed and the effect this has had on its
cash position. An entity that wishes to disclose additional information over and above the minimum required
under the Listing Rules is encouraged to do so.
2.
If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the
definitions in, and provisions of, AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow
report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing
Rule 19.11A, the corresponding equivalent standard applies to this report.
3.
Dividends received may be classified either as cash flows from operating activities or cash flows from investing
activities, depending on the accounting policy of the entity.
4.
If this report has been authorised for release to the market by your board of directors, you can insert here: “By the
board”. If it has been authorised for release to the market by a committee of your board of directors, you can insert
here: “By the [name of board committee – e.g., Audit and Risk Committee]”. If it has been authorised for release to
the market by a disclosure committee, you can insert here: “By the Disclosure Committee”.
5.
If this report has been authorised for release to the market by your board of directors and you wish to hold yourself
out as complying with recommendation 4.2 of the ASX Corporate Governance Council’s Corporate Governance
Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in
their opinion, the financial records of the entity have been properly maintained, that this report complies with the
appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their
opinion has been formed on the basis of a sound system of risk management and internal control which is
operating effectively.
HITIQ.COM
Share your feedback
Discover